BSL — Bhayani Securities (Pvt) Ltd.
SEARL logo

Rs 79.60 ▲ +0.42 (+0.53%)As of 15:16

View SEARL share price

The Searle Company Limited: Presentation of Corporate Briefing Session

Corporate BriefingSTRONGLY POSITIVE

Key facts

Date
Friday, November 20, 2026
Venue
Zoom meeting
Registration deadline
November 19, 2026, by 5:00 p.m.
See the notice →

What this means: This is an informational session on Friday, November 20, 2026 for shareholders and analysts; to attend, register by November 19, 2026, by 5:00 p.m.

The Searle Company Limited held a corporate briefing session outlining its organizational structure, product categories, and recent financial performance, highlighting strong growth and profitability improvements.

  • The session detailed the IBL Group's diversified business platform, including operations in pharmaceuticals, distribution, IT, and retail.
  • Searle is ranked 1st in cardiovascular, gynecology, and cough suppressant categories, and is the fourth largest pharmaceutical company in Pakistan by units sold.
  • FY 2026 standalone sales reached PKR 16.75B, with a profit after tax of PKR 31.64B, showing significant growth from FY 2025.
  • Consolidated performance for FY 2026 also showed strong results with sales of PKR 36.81B and a return to profitability with a profit after tax of PKR 536M.
  • Q1 FY 2027 consolidated sales increased by 31% year-on-year, with profit after tax rising to PKR 1.19B.
  • The company continues to focus on expanding its product offerings across 16 therapeutic areas, ensuring broad market coverage and brand leadership.

About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange, per our editorial policy and data methodology. A summary for information, not investment advice — the original filing is the authoritative record.

Trade SEARL with BSL

Act on this filing with live PSX data, research support, and a broker built for it.

Open an account